Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nasopharyngeal Carcinoma × Population Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Neoplasms 4 Pain, Postoperative 2 Hemangioma, Capillary 2 Carcinoma, Hepatocellular 2 Anxiety Disorders 2 Weight Loss 1 Vomiting 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Small Cell Lung Carcinoma 1 Shoulder Pain 1 Respiratory Aspiration 1 Psychomotor Agitation 1 Prostatic Neoplasms 1 Premature Birth 1 Polycystic Ovary Syndrome 1 Pediatric Obesity 1 Ovarian Cysts 1 Obesity 1 Neuromuscular Diseases 1 Nasopharyngeal Carcinoma 1 Myofibroma 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Multiple Myeloma 1 Menstruation Disturbances 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1

Interventions

Cisplatin 117 Gemcitabine 66 Radiotherapy, Intensity-Modulated 53 toripalimab 34 Capecitabine 34 Fluorouracil 32 Docetaxel 32 Radiotherapy 21 camrelizumab 19 Drug Therapy 19 nimotuzumab 18 spartalizumab 12 pembrolizumab 12 nedaplatin 12 apatinib 11 Induction Chemotherapy 10 tislelizumab 9 sintilimab 9 Magnetic Resonance Spectroscopy 9 Chemoradiotherapy 9 Carboplatin 9 Specimen Handling 8 Nivolumab 8 Cetuximab 8 Bevacizumab 8 endostar protein 7 Paclitaxel 7 Immune Checkpoint Inhibitors 7 Endostatins 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01536223 2013-03-05

ESNCCT

Zhejiang Cancer Hospital

Phase 3 Unknown

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡